![]() |
|
|
Vol. 26, Issue 2, 164-169, February 1998
Department of Pharmacology, Faculty of Medicine, University of
Montréal
The kinetics of propranolol enantiomers are stereoselective when
high doses of the racemic drug are given po. To document whether the
dose and/or the route of administration determines the stereoselective
kinetics of propranolol enantiomers, conscious rabbits received 40, 80, or 120 mg/kg po or 0.5 or 10 mg/kg iv doses of racemic propranolol, and
serial blood samples were obtained to assay propranolol enantiomers. At
low po and iv doses, the kinetics of the propranolol enantiomers were
identical. After the 120 mg/kg po dose, the kinetics of the enantiomers
were stereoselective, i.e. the
AUC0
for (S)-(
)-propranolol
was greater than the AUC0
for
(R)-(+)-propranolol (p < 0.05). The iv injection of 10 mg/kg generated zero-order kinetics, and (S)-(
)-propranolol was eliminated faster than the
antipode. Propranolol enantiomer plasma protein binding was not
stereoselective. In vitro, after the incubation of 5.8 or
58 µM (RS)-propranolol with cells of the intestinal
mucosa or the liver, (R)-(+)-propranolol was more rapidly
metabolized than (S)-(
)-propranolol at both concentrations in the intestine and at the higher concentration in the
liver. Incubation of the individual enantiomers (2.9 and 29 µM)
showed that in the intestine the intrinsic clearance of (R)-(+)-propranolol was greater than that of
(S)-(
)-propranolol but in the liver there was
preferential saturation of (S)-(
)-propranolol clearance.
In conclusion, at low po or iv doses the kinetics of (RS)-propranolol are not stereoselective because the liver
overshadows the effect of the intestine, and at high po doses the
kinetics of propranolol enantiomers are stereoselective because of
hepatic saturation of (S)-(
)-propranolol clearance.
This article has been cited by other articles:
![]() |
D. Y. Hung, G. A. Siebert, P. Chang, Y. G. Anissimov, and M. S. Roberts Disposition Kinetics of Propranolol Isomers in the Perfused Rat Liver J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 822 - 829. [Abstract] [Full Text] [PDF] |
||||